Radstake TR - Search Results

1

The role of genetics and epigenetics in the pathogenesis of systemic sclerosis.

Broen JC, Radstake TR, Rossato M. Broen JC, et al. Among authors: radstake tr. Nat Rev Rheumatol. 2014 Nov;10(11):671-81. doi: 10.1038/nrrheum.2014.128. Epub 2014 Aug 19. Nat Rev Rheumatol. 2014. PMID: 25136786 Review.

2

Role of Fcgamma receptors IIA, IIIA, and IIIB in susceptibility to rheumatoid arthritis.

Radstake TR, Petit E, Pierlot C, van de Putte LB, Cornelis F, Barrera P. Radstake TR, et al. J Rheumatol. 2003 May;30(5):926-33. J Rheumatol. 2003. PMID: 12734884

3

The functional variant (Asp299gly) of toll-like receptor 4 (TLR4) influences TLR4-mediated cytokine production in rheumatoid arthritis.

Roelofs MF, Wenink MH, Toonen EJ, Coenen MJ, Joosten LA, van den Berg WB, van Riel PL, Radstake TR. Roelofs MF, et al. Among authors: radstake tr. J Rheumatol. 2008 Apr;35(4):558-61. Epub 2008 Mar 15. J Rheumatol. 2008. PMID: 18381796

4

The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.

Rueda B, Broen J, Torres O, Simeon C, Ortego-Centeno N, Schrijvenaars MM, Vonk MC, Fonollosa V, van den Hoogen FH, Coenen MJ, Sanchez-Román J, Aguirre-Zamorano MA, García-Portales R, Pros A, Camps MT, Gonzalez-Gay MA, Martin J, Radstake TR. Rueda B, et al. Among authors: radstake tr. Ann Rheum Dis. 2009 Feb;68(2):253-6. doi: 10.1136/ard.2008.096719. Epub 2008 Aug 19. Ann Rheum Dis. 2009. PMID: 18713787

5

The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patients.

Radstake TR, Vonk MC, Dekkers M, Schijvenaars MM, Treppichio WL, Lafyatis R, Riemekasten G, van den Hoogen F, Coenen MJ. Radstake TR, et al. Hum Immunol. 2009 Feb;70(2):130-3. doi: 10.1016/j.humimm.2008.10.012. Epub 2008 Nov 24. Hum Immunol. 2009. PMID: 19032966

6

A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype.

Rueda B, Simeon C, Hesselstrand R, Herrick A, Worthington J, Ortego-Centeno N, Riemekasten G, Fonollosa V, Vonk MC, van den Hoogen FH, Sanchez-Román J, Aguirre-Zamorano MA, García-Portales R, Pros A, Camps MT, Gonzalez-Gay MA, Gonzalez-Escribano MF, Coenen MJ, Lambert N, Nelson JL, Radstake TR, Martin J. Rueda B, et al. Among authors: radstake tr. Ann Rheum Dis. 2009 Oct;68(10):1618-20. doi: 10.1136/ard.2008.100180. Epub 2008 Dec 3. Ann Rheum Dis. 2009. PMID: 19054816 Free PMC article.

7

Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.

van Lieshout AW, Vonk MC, Bredie SJ, Joosten LB, Netea MG, van Riel PL, Lafyatis R, van den Hoogen FH, Radstake TR. van Lieshout AW, et al. Among authors: radstake tr. Scand J Rheumatol. 2009;38(4):282-90. doi: 10.1080/03009740802572467. Scand J Rheumatol. 2009. PMID: 19255934

8

Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.

Popa C, Netea MG, de Graaf J, van den Hoogen FH, Radstake TR, Toenhake-Dijkstra H, van Riel PL, van der Meer JW, Stalenhoef AF, Barrera P. Popa C, et al. Among authors: radstake tr. J Rheumatol. 2009 Apr;36(4):724-30. doi: 10.3899/jrheum.080626. Epub 2009 Feb 27. J Rheumatol. 2009. PMID: 19273452

9

The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype.

Rueda B, Broen J, Simeon C, Hesselstrand R, Diaz B, Suárez H, Ortego-Centeno N, Riemekasten G, Fonollosa V, Vonk MC, van den Hoogen FH, Sanchez-Román J, Aguirre-Zamorano MA, García-Portales R, Pros A, Camps MT, Gonzalez-Gay MA, Coenen MJ, Airo P, Beretta L, Scorza R, van Laar J, Gonzalez-Escribano MF, Nelson JL, Radstake TR, Martin J. Rueda B, et al. Among authors: radstake tr. Hum Mol Genet. 2009 Jun 1;18(11):2071-7. doi: 10.1093/hmg/ddp119. Epub 2009 Mar 13. Hum Mol Genet. 2009. PMID: 19286670

10

The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases.

Kurreeman FA, Goulielmos GN, Alizadeh BZ, Rueda B, Houwing-Duistermaat J, Sanchez E, Bevova M, Radstake TR, Vonk MC, Galanakis E, Ortego N, Verduyn W, Zervou MI, Roep BO, Dema B, Espino L, Urcelay E, Boumpas DT, van den Berg LH, Wijmenga C, Koeleman BP, Huizinga TW, Toes RE, Martin J; AADEA Group; SLEGEN Consortium. Kurreeman FA, et al. Among authors: radstake tr. Ann Rheum Dis. 2010 Apr;69(4):696-9. doi: 10.1136/ard.2008.106567. Epub 2009 May 10. Ann Rheum Dis. 2010. PMID: 19433411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results